Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio

Surgery for Obesity and Related Diseases

Volumn 9, Issue 1, 2013, Pages 100-107

  Heneghan, Helen M ^a   Huang, Hazel ^a   Kashyap, Sangeeta R ^a   Gornik, Heather L ^a   McCullough, Arthur J ^a   Schauer, Philip R ^a   Brethauer, Stacy A ^a   Kirwan, John P ^a   Kasumov, Takhar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ApoA1; ApoB100; ApoB100 ApoA1 ratio; Apolipoproteins; Bariatric surgery; Cardiovascular risk; Ceramide; Roux en Y gastric bypass; Sphingolipids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; BIOCHEMICAL MARKER; CERAMIDE; CHOLESTEROL; FATTY ACID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL PATIENT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CERAMIDES; FEMALE; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84873056154     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2011.11.018     Document Type: Article

References (35)

1. H.B. Hubert, M. Feinleib, P.M. McNamara, W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study Circulation 67 1983 968 977
2. J.P. Castro, F.A. El-Atat, S.I. McFarlane, A. Aneja, J.R. Sowers Cardiometabolic syndrome: pathophysiology and treatment Curr Hypertens Rep 5 2003 393 401
3. H.J. Sugerman, E.J. DeMaria, W.L. Felton III, M. Nakatsuka, A. Sismanis Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri Neurology 49 1997 507 511
4. J.D. Brunzell, J.E. Hokanson Dyslipidemia of central obesity and insulin resistance Diabetes Care 22 Suppl 3 1999 C10 C13
5. L.A. Vázquez, F. Pazos, J.R. Berrazueta Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery J Clin Endocrinol Metab 90 2005 316 322
6. K.R. Kelly, S.R. Kashyap, V.B. O'Leary, J. Major, P.R. Schauer, J.P. Kirwan Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients Obes Silver Spring 18 2010 663 666
7. C.M. Ballantyne, R.C. Hoogeveen, H. Bang Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the atherosclerosis risk in communities (ARIC) study Circulation 109 2004 837 842
8. J.D. Horton, N.A. Shah, J.A. Warrington Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes Proc Natl Acad Sci U S A 100 2003 12027 12032
9. S. Marcovina, C.J. Packard Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels J Intern Med 259 2006 437 446
10. S. Holewijn, M. den Heijer, D.W. Swinkels, A.F. Stalenhoef, J. de Graaf Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk J Intern Med 268 2010 567 577
11. I. Arimoto, H. Saito, Y. Kawashima, K. Miyajima, T. Handa Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions J Lipid Res 39 1998 143 151
12. M.R. Hojjati, Z. Li, H. Zhou Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice J Biol Chem 280 2005 10284 10289
13. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033
14. G. Walldius, I. Jungner, A.H. Aastveit, I. Holme, C.D. Furberg, A.D. Sniderman The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk Clin Chem Lab Med 42 2004 1355 1363
15. P. Gatmaitan, H. Huang, J. Talarico Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool Surg Obes Relat Dis 6 2010 532 537
16. F. Samad, K.D. Hester, G. Yang, Y.A. Hannun, J. Bielawski Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk Diabetes 55 2006 2579 2587
17. S.A. Brethauer, H.M. Heneghan, S. Eldar Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients Surg Endosc 25 2011 2650 2659
18. H. Huang, T. Kasumov, P. Gatmaitan Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients Obesity 19 2011 2235 2240
19. National Institutes of Health Conference Gastrointestinal surgery for severe obesity Consensus Development Conference Panel Ann Intern Med 115 1991 956 961
20. P.R. Schauer, B. Burguera, S. Ikramuddin Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 2003 467 485
21. T. Kasumov, H. Huang, Y.M. Chung, R. Zhang, A.J. McCullough, J.P. Kirwan Quantification of ceramide species in biological samples by liquid chromatography-electrospray ionization tandem mass spectrometry Anal Biochem 401 2010 154 161
22. J.T. Kuvin, A.R. Patel, K.A. Sliney Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease J Am Coll Cardiol 38 2001 1843 1849
23. B. Takase, A. Uehata, T. Akima Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease Am J Cardiol 82 1998 1535 1539 A7-8
24. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
26. J.B. Buse, S. Caprio, W.T. Cefalu How do we define cure of diabetes? Diabetes Care 32 2009 2133 2135
27. L. Sjöström, K. Narbro, C.D. Sjöström Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 2007 741 752
28. K.K. Koh, P.C. Oh, M.J. Quon Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res 81 2009 649 659
29. G.A. Rosito, J.M. Massaro, U. Hoffmann Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study Circulation 117 2008 605 613
30. J. Kullberg, M. Sundbom, A. Haenni Gastric bypass promotes more lipid mobilization than a similar weight loss induced by low-calorie diet J Obes 2011 2011 959-601
31. S. Klein, B. Mittendorfer, J.C. Eagon Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 2006 1564 1572
32. D.M. Culnan, R.N. Cooney, B. Stanley, C.J. Lynch Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass Obesity (Silver Spring) 17 2009 46 52
33. F. Taylor, K. Ward, T.H. Moore Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 2011 CD004816
34. A. Cachefo, P. Boucher, E. Dusserre, P. Bouletreau, M. Beylot, C. Chambrier Stimulation of cholesterol synthesis and hepatic lipogenesis in patients with severe malabsorption J Lipid Res 44 2003 1349 1354
35. T.S. Worgall Regulation of lipid metabolism by sphingolipids Subcell Biochem 49 2008 371 385